10.4% revenue growth qualifies as fast grower, but PEG of 5.2 and zero insider buying signal the easy gains are history.
This framework sees a fast grower with 10.4% revenue growth and expanding 17% earnings, but the PEG of 5.2 and institutional ownership above 100% suggest the easy money has been made.
What type of company is this and what should we expect?
This framework classifies IDEXX as a fast grower transitioning toward stalwart territory — revenue growth just above 10% threshold but decelerating from higher levels. The veterinary diagnostics focus and inflation correlation provide defensive characteristics unusual for fast growers.
Is the price reasonable for the growth we're getting?
Applying this lens shows a PEG far above Lynch's comfort zone of 1.0 — paying 5x the growth rate violates fundamental value principles. The framework would classify this as "paying for the yacht" territory where growth expectations are priced to perfection.
Can you explain the growth in one sentence a child would understand?
This framework appreciates the simplicity — everyone understands taking pets to the vet. The recurring nature of diagnostics (instruments need consumables, pets need regular testing) creates a predictable growth story that Lynch would favor.
Is this overowned by the big money?
This framework sees maximum saturation — when institutions own more than 100%, there's literally no one left to buy. Lynch would call this "overowned" and look elsewhere, as the discovery phase ended long ago.
Applying this framework reveals a quality fast grower that has graduated to institutional darling status, with a simple story ("pet diagnostics") but a PEG of 5.2 that would make Lynch look elsewhere. The 100.6% institutional ownership confirms what the absent insider buying suggests — the discovery phase ended quarters ago. Would Lynch rather own a boring company at 10x earnings with insiders buying, or this wonderful business at 55x with insiders selling?
This analysis applies Peter Lynch's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Peter Lynch. Educational purposes only. Not financial advice.